Evidence map›Paper›PMID 40267395›Full record

ArticleEuropean journal of public health2025

Cervical cancer mortality trend in Montenegro-1990-2018.

Mirjana Nedović Vuković, Snežana Barjaktarović Labović, Marina Jakšić, Ljiljana Vučković, Adrijana Vujović

Abstract read
In one paragraph

Article in European journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mirjana Nedović VukovićCentre for Health System Evidence and Research in Public Health, Institute for Public Health of Montenegro, Podgorica, Montenegro.
Snežana Barjaktarović LabovićFaculty of Medicine, University of Montenegro, Podgorica, Montenegro.
Marina JakšićFaculty of Medicine, University of Montenegro, Podgorica, Montenegro.
Ljiljana VučkovićFaculty of Medicine, University of Montenegro, Podgorica, Montenegro.
Adrijana VujovićCentre for Chronic Non-communicable Diseases, Institute for Public Health of Montenegro, Podgorica, Montenegro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is the fourth leading cause of cancer-related deaths in women, resulting in an estimated 350 000 deaths worldwide in 2022. Public health preventive strategies can modify the burden of cervical cancer. This study aimed to assess the mortality trends of cervical cancer in Montenegro from 1990 to 2018 and identify the impact of preventive measures on mortality rates associated with cervical cancer. The data concerning cervical cancer mortality from 1990 to 2018 were collected. The joinpoint, linear, and Poisson regressions were applied. The rate was adjusted to the world standard population. Overall and age-specific trends were assessed. Joinpoint regression revealed a statistically significant increase in cervical cancer mortality rates by an average of 2.6% per year [average annual percentage change (AAPC) (95%CI) = 2.6 (1.3-3.8); P < .001] and the number of death cases by 3.5% [AAPC (95%CI) = 3.5 (2.2-4.7); P < .001] for the overall level for the period 1990-2018. Among the women who died from cervical cancer, the majority were aged 55-64 (28.3%), then aged 45-54 (27.6%) and aged 65-74 (17.4%). This analysis highlights a growing trend of mortality from cervical cancer in Montenegro, underscoring the need for additional research into the causes of this serious public health concern.

Indexed as

Uterine Cervical NeoplasmsAdolescentAdultAgedFemaleHumansMiddle AgedMontenegroMortalityYoung Adult

Identifiers

PMID40267395
PMCPMC12199348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.